These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28561239)

  • 1. Determination of Fenofibric Acid in Rat Plasma and its Application to a Comparative Pharmacokinetic Study of JW322 and Fenofibrate.
    Kim TK
    Drug Res (Stuttg); 2017 Sep; 67(9):534-538. PubMed ID: 28561239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry.
    Wei X; Li P; Liu M; Du Y; Wang M; Zhang J; Wang J; Liu H; Liu X
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27594083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated high-performance liquid chromatography method for the determination of a phosphodiesterase inhibitor SK5474 in rat plasma and its application to pharmacokinetic study of SK5474.
    Kim TK; Ji YS; Jung OH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():9-12. PubMed ID: 25899974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of SK3497 in rat plasma and its application in a pharmacokinetic study of SK3497.
    Kim TK; Ji YS; Park MH; Kim CH
    Drug Res (Stuttg); 2014 Dec; 64(12):647-50. PubMed ID: 24918347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG
    Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validated high-performance liquid chromatography method for the determination of the inhibitor of cancer cell invasion (E)-N-benzyl-6-[2-(3, 4-dihydroxy benzylidene)hydrazinyl]-N-methylpyridine-3-sulfonamide in rat plasma and its application to pharmacokinetic study.
    Kim TK; Choi HK
    Biomed Chromatogr; 2017 May; 31(5):. PubMed ID: 27809343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of fenofibric acid in rat plasma.
    Wang G; Guo J; Meng F; Song X; Zhong B; Zhao Y
    Biomed Chromatogr; 2012 Apr; 26(4):497-501. PubMed ID: 21882209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of pharmacokinetics and NO-releasing of nitrofibriate and fenofibrate after oral administration in rats.
    Yang Y; Cheng Q; Liu X; Liu Z; Li T; Jiang X; Wang L
    Biomed Chromatogr; 2016 Dec; 30(12):2003-2008. PubMed ID: 27270950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography.
    Streel B; Hubert P; Ceccato A
    J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):391-400. PubMed ID: 10901144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine].
    Abe S; Ono K; Mogi M; Hayashi T
    Yakugaku Zasshi; 1998 Oct; 118(10):447-55. PubMed ID: 9800517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of a UPLC-MS/MS method for simultaneous determination of fenofibric acid and berberine in rat plasma: application to the drug-drug pharmacokinetic interaction study of fenofibrate combined with berberine after oral administration in rats.
    Li G; Yang F; Liu M; Su X; Zhao M; Zhao L
    Biomed Chromatogr; 2016 Jul; 30(7):1075-1082. PubMed ID: 26577601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated High-performance Liquid Chromatography Method for the Determination of JW5624, A New Class Of Hepatitis C Virus Inhibitor, in Rat Plasma and its Application in the Pharmacokinetic Study of JW5624.
    Kim TK
    Drug Res (Stuttg); 2021 Jul; 71(6):312-316. PubMed ID: 33535254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of fenofibric acid in lipoprotein fractions of patients.
    Nobilis M; Kvetina J; Anzenbacher P; Vontor T; Svoboda D; Brátová M; Solichová D; Zadák Z; Bláha V; Vlcek J
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):287-94. PubMed ID: 9725495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography.
    Masnatta LD; Cuniberti LA; Rey RH; Werba JP
    J Chromatogr B Biomed Appl; 1996 Dec; 687(2):437-42. PubMed ID: 9017468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC-MS/MS method and its application to pharmacokinetic studies.
    Zheng Y; Liu H; Ma G; Yang P; Zhang L; Gu Y; Zhu Q; Shao T; Zhang P; Zhu Y; Cai W
    J Pharm Biomed Anal; 2011 Apr; 54(5):1187-91. PubMed ID: 21156344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics.
    Alamri RG; Mohsin K; Ahmad A; Raish M; Alanazi FK
    Saudi Pharm J; 2017 Jan; 25(1):128-135. PubMed ID: 28223873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
    Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
    J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers.
    Pan WJ; Gustavson LE; Achari R; Rieser MJ; Ye X; Gutterman C; Wallin BA
    J Clin Pharmacol; 2000 Mar; 40(3):316-23. PubMed ID: 10709162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised crossover studies of the bioequivalence of two fenofibrate formulations after administration of a single oral dose in healthy volunteers.
    Sonet B; Vanderbist F; Streel B; Houin G
    Arzneimittelforschung; 2002; 52(3):200-4. PubMed ID: 11963648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-UV method development and validation for 16-dehydropregnenolone, a novel oral hypolipidaemic agent, in rat biological matrices for application to pharmacokinetic studies.
    Singh SK; Mehrotra N; Sabarinath S; Gupta RC
    J Pharm Biomed Anal; 2003 Nov; 33(4):755-64. PubMed ID: 14623602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.